| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |